Baxter Declares Quarterly Dividend

DEERFIELD, Ill.–(BUSINESS WIRE)–Baxter International Inc. (NYSE:BAX), a global medtech leader, today announced that its Board of Directors has declared a quarterly cash dividend of $0.29 per share of common stock. The dividend is payable on Oct. 1, 2024, to stockholders of record as of Aug. 30, 2024. The indicated annual dividend rate is $1.16 per … [Read more…]

KAID Health and Park Medical Announce Strategic Partnership to Enhance Coding Accuracy, Efficiency and Care Quality

SOUTHFIELD, Mich. & BOSTON–(BUSINESS WIRE)–KAID Health and Park Medical Centers (PMC) are excited to announce a strategic partnership. KAID Health’s Artificial Intelligence (AI) and medical coders are supporting Park clinicians in better delivering the high-quality, empathetic care that PMC is known for throughout the metro-Detroit area. With KAID Health, all data in Park’s electronic medical … [Read more…]

Interrad Medical’s SecurAcath is Superior to Standard of Care in Newly Published Randomized Controlled Clinical Study

PLYMOUTH, Minn.–(BUSINESS WIRE)–Interrad Medical, Inc., a privately held medical device company, announces excellent results of a clinical study published in JAMA Pediatrics titled, “Securement to prevent non-cuffed central venous catheter dislodgement in pediatrics The SECURED superiority randomized clinical trial,” Kleidon, et al. This multi-center, randomized controlled trial was undertaken in partnership with The Queensland Children’s … [Read more…]

Lucet’s 2024 Validation Report Quantifies the Significant Cost Savings Associated with Navigate & Connect

OVERLAND PARK, Kan.–(BUSINESS WIRE)–Lucet, the behavioral health ecosystem for health plans, providers and members, today announced the results of the company’s 2024 Validation Report. Certified with the Validation Institute, the cost savings analysis verified that members who were navigated to an appointment with a behavioral health provider through Lucet’s Navigate & Connect had claims-verified lower … [Read more…]

Orthofix Names Stephanie Walsh Chief Human Resources Officer

LEWISVILLE, Texas–(BUSINESS WIRE)–Orthofix Medical Inc. (NASDAQ:OFIX), a leading global spine and orthopedics company, today announced the appointment of Stephanie Walsh as Chief Human Resources Officer. A seasoned human resources executive, Walsh joins Orthofix from ResMed Inc., a San Diego-based medical device company, where she served most recently as Vice President of Transformation. During her tenure … [Read more…]

Azafaros announces positive topline Phase 2 study data with nizubaglustat in GM2 gangliosidosis and Niemann-Pick disease type C

Study designed to support safety profile showed nizubaglustat was safe and well tolerated Results support continued development of nizubaglustat for GM2 gangliosidosis and Niemann-Pick disease type C with Phase 3 trial[s] planned for 2025 Data to be presented at the SSIEM Annual Symposium 2024 to be held 3-6 September in Porto, Portugal LEIDEN, Netherlands–(BUSINESS WIRE)–#Azafaros–Azafaros … [Read more…]

SamanTree Medical Raises $14M in Series B Financing Round to Support Global Expansion and Innovation in Surgical Treatment

Henry Charlton and Claire Poulard to join the Board of Directors Funding will Accelerate US Market Entry, Enhance Digital Solutions, and Support Clinical Developments LAUSANNE, Switzerland & LIÈGE, Belgium–(BUSINESS WIRE)–SamanTree Medical, a leading medical technology company specializing in innovative solutions to improve the outcomes of surgery, today announced the closing of $14M as part of … [Read more…]

AriBio Co., Ltd. and Fujirebio Diagnostics, Inc. Announce Milestone Achievement to Advance Biomarker Development for Alzheimer’s Disease and Neurodegeneration

SAN DIEGO & TOKYO & MALVERN, Pa.–(BUSINESS WIRE)–Fujirebio Holdings Inc., its wholly-owned subsidiary Fujirebio Diagnostics, Inc., and AriBio Co., Ltd. announced today the attainment of the first milestone in a strategic partnership to advance the development of biomarkers for Alzheimer’s disease (AD) and other neurodegenerative conditions. This milestone marks a key achievement which provides Fujirebio … [Read more…]

Generali Health Solutions Selects Modern Health As Exclusive Mental Health Partner

Generali Health Solutions Extends Modern Health To Its International Customers SYDNEY–(BUSINESS WIRE)–Modern Health, a leading global workplace mental health platform, and Generali Health Solutions GmbH, today are announcing an exclusive partnership. Being a provider of proven effective health programs, Generali Health Solutions GmbH is part of the international Generali Group, one of the largest global … [Read more…]

Omnicell to Release Second Quarter 2024 Financial Results on August 1, 2024

FORT WORTH, Texas–(BUSINESS WIRE)–Omnicell, Inc. (Nasdaq:OMCL), a leader in transforming the pharmacy care delivery model, will release its financial results for the second quarter 2024, before market open on Thursday, August 1, 2024. The Company will host a conference call and webcast to discuss its financial results at 8:30 a.m. ET that same day. All … [Read more…]